Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for the Treatment of Metastatic/Recurrent Advanced Solid Tumors
Clinical trial NCT05430360 · TERMINATED
Trial details
- NCT number
- NCT05430360
- Sponsor
- Grit Biotechnology
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-04
- Primary completion
- 2025-12-30
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.